We are live on ! Find out more
Ensign Peak Advisors

Ensign Peak Advisors Portfolio holdings

AUM $53.7B
1-Year Est. Return 29.47%
This Fund
S&P 500
This Quarter Est. Return
+12.76%
1 Year Est. Return
+29.47%
3 Year Est. Return
+102.45%
5 Year Est. Return
+139.11%
10 Year Est. Return
AUM
$50.5B
AUM Growth
+$3.68B
Cap. Flow
-$1.47B
Cap. Flow %
-2.92%
Top 10 Hldgs %
27.58%
Holding
1,779
New
23
Increased
1,010
Reduced
375
Closed
40

Top Sells

Rank Stock Value
1
WMT icon
Walmart Inc
WMT
+$215M
2
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$200M
3
UNH icon
UnitedHealth
UNH
+$183M
4
AAPL icon
Apple
AAPL
+$133M
5
AZN icon
AstraZeneca
AZN
+$121M

Sector Composition

Rank Sector Weight
1 Technology 27.26%
2 Healthcare 15.74%
3 Financials 12.66%
4 Consumer Discretionary 9.73%
5 Industrials 7.52%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
KVYO icon
1726
Klaviyo
KVYO
$5.31B
$135K ﹤0.01%
4,860
+138
+3% +$4.08K
PRM icon
1727
Perimeter Solutions
PRM
$5.44B
$132K ﹤0.01%
28,668
ERAS icon
1728
Erasca
ERAS
$6.55B
$107K ﹤0.01%
50,000
NUVB icon
1729
Nuvation Bio
NUVB
$2.32B
$96.3K ﹤0.01%
63,763
WB icon
1730
Weibo
WB
$1.92B
$89.8K ﹤0.01%
8,200
CART icon
1731
Maplebear
CART
$10.4B
$85.4K ﹤0.01%
3,639
+1,283
+54% +$32.3K
LU icon
1732
Lufax Holding
LU
$1.27B
$58.6K ﹤0.01%
19,075
VIRX
1733
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
$36.1K ﹤0.01%
63,406
KRON
1734
DELISTED
Kronos Bio
KRON
$20.2K ﹤0.01%
16,150
BCEL
1735
DELISTED
Atreca, Inc. Class A Common Stock
BCEL
$13.9K ﹤0.01%
105,283
SYBX
1736
DELISTED
Synlogic
SYBX
$8.5K ﹤0.01%
2,207
DNA.WS
1737
DELISTED
Ginkgo Bioworks Holdings, Inc. Warrants, each whole warrant exercisable to purchase one-fortieth (1/40th) of a share of Class A Common Stock at an exercise price of $460.00 per share
DNA.WS
$1.7K ﹤0.01%
16,100
ABCL icon
1738
AbCellera Biologics
ABCL
$1.6B
-166,000
Closed -$764K
AMWL icon
1739
American Well
AMWL
$185M
-670
Closed -$15.7K
ANIK icon
1740
Anika Therapeutics
ANIK
$200M
-16,300
Closed -$304K
ATXS
1741
DELISTED
Astria Therapeutics
ATXS
-65,000
Closed -$485K
AVD icon
1742
American Vanguard Corp
AVD
$75.2M
-22,867
Closed -$250K
CHPT icon
1743
ChargePoint
CHPT
$140M
-4,644
Closed -$462K
VISN
1744
Vistance Networks Inc
VISN
$2.67B
-98,000
Closed -$329K
ENTA icon
1745
Enanta Pharmaceuticals
ENTA
$370M
-20,250
Closed -$226K
FARO
1746
DELISTED
Faro Technologies
FARO
-15,860
Closed -$242K
FF icon
1747
Future Fuel
FF
$203M
-38,509
Closed -$276K
MCHB
1748
Mechanics Bancorp
MCHB
$3.46B
-18,738
Closed -$146K
IOT icon
1749
Samsara
IOT
$20.6B
-37,200
Closed -$938K
LAZR
1750
DELISTED
Luminar Technologies
LAZR
-7,004
Closed -$478K

Similar funds

Ensign Peak Advisors's Q4 2023 Portfolio in Review

As of Q4 2023, Ensign Peak Advisors held 1,779 positions worth $50.5B, up 7.8% from $46.8B the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Trading was light in Q4 2023: portfolio turnover was 3.5%. Ensign Peak Advisors opened 23 new positions and exited 40, leaving the 1,779-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 24% a quarter earlier, followed by Healthcare and Financials.

  • Ensign Peak Advisors's largest Q4 2023 buy was State Street SPDR S&P 500 ETF Trust: 140,000 shares worth $66.5M.
  • Ensign Peak Advisors added most to Estee Lauder in Q4 2023, an estimated $137M increase.
  • Ensign Peak Advisors's biggest Q4 2023 reduction was Walmart Inc, cutting an estimated $215M.
  • Ensign Peak Advisors fully exited Invesco QQQ Trust in Q4 2023, selling an estimated $57.3M.
  • Ensign Peak Advisors's ten largest holdings make up 28% of its $50.5B portfolio in Q4 2023.
  • Ensign Peak Advisors opened 23 new positions and closed 40 in Q4 2023.
  • Ensign Peak Advisors's portfolio value rose 7.8% quarter-over-quarter to $50.5B.

Based on Ensign Peak Advisors's 13F filing for Q4 2023, filed 14 Feb 2024.